Karyopharm Therapeutics
KPTI
KPTI
149 hedge funds and large institutions have $303M invested in Karyopharm Therapeutics in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 58 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 58
39% less capital invested
Capital invested by funds: $499M → $303M (-$197M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
149
Holding in Top 10
–
Calls
$4.7M
Puts
$1.92M
Top Buyers
| 1 | +$7.5M | |
| 2 | +$3.89M | |
| 3 | +$3.57M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$2.83M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.6M |
Top Sellers
| 1 | -$7.33M | |
| 2 | -$4.06M | |
| 3 | -$2.92M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$2.92M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.87M |